A Study of TAK-659 in Combination With NKTR-214 in Participants With Advanced Non-Hodgkin Lymphoma (NHL)

NCT03772288 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business Decision: No Safety or Efficacy Concerns

Conditions

Lymphoma, Non-Hodgkin

Interventions

DRUG: TAK-659
DRUG: NKTR-214

Sponsor

Calithera Biosciences, Inc

Collaborators

[object Object]